Status:

RECRUITING

Pathogenic Study of Adult Immune Enteropathies

Lead Sponsor:

Institut National de la Santé Et de la Recherche Médicale, France

Collaborating Sponsors:

Imagine Institute

Conditions:

Celiac Disease

Autoimmune Enteropathy

Eligibility:

All Genders

18+ years

Brief Summary

The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel ...

Eligibility Criteria

Inclusion

  • 18 years or over
  • affiliated to social insurance
  • signed informed consent

Exclusion

  • pregnancy
  • under guardianship
  • not able to sign informed consent

Key Trial Info

Start Date :

February 27 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 27 2033

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04280510

Start Date

February 27 2020

End Date

February 27 2033

Last Update

September 18 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hôpital Henri Mondor

Créteil, France, 94010

2

Hôpital Bicêtre

Le Kremlin-Bicêtre, France, 94270

3

Hôpital Saint Louis

Paris, France, 75010

4

Hôpital Cochin

Paris, France, 75014

Pathogenic Study of Adult Immune Enteropathies | DecenTrialz